ID   SBDS-iPS1
AC   CVCL_C736
SY   SBDS-IPS1
DR   Wikidata; Q54952201
RX   Patent=US20110151447;
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
DI   NCIt; C61235; Shwachman-Diamond syndrome
DI   ORDO; Orphanet_811; Shwachman-Diamond syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C737 ! SBDS-iPS2
OI   CVCL_C738 ! SBDS-iPS3
OI   CVCL_C739 ! SBDS-iPS8
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
RX   Patent=US20110151447;
RA   Park, In-Hyun
RA   Daley, George Quentin
RA   Agarwal, Suneet
RA   Lerou, Paul Hubert
RT   "Method to produce induced pluripotent stem (iPS) cells from
RT   non-embryonic human cells.";
RL   Patent number US20110151447, 23-Jun-2011.
//
RX   PubMed=18691744; DOI=10.1016/j.cell.2008.07.041; PMCID=PMC2633781;
RA   Park, In-Hyun
RA   Arora, Natasha
RA   Huo, Hong-Guang
RA   Maherali, Nimet
RA   Ahfeldt, Tim
RA   Shimamura, Akiko
RA   Lensch, M. William
RA   Cowan, Chad A.
RA   Hochedlinger, Konrad
RA   Daley, George Quentin
RT   "Disease-specific induced pluripotent stem cells.";
RL   Cell 134:877-886(2008).
//